Egaten

Chemical Nametriclabendazole
Dosage FormTablet (oral; 250 mg)
Drug ClassAntihelmintics
SystemMultiple
CompanyNovartis
Approval Year2019

Indication

  • For the treatment of fascioliasis in patients 6 years of age and older.
Last updated on 11/16/2022

More on this drug: Clinical Trials

Document TitleYearSource
Egaten (triclabendazole) Prescribing Information.2022Novartis Pharmaceuticals Corporation, East Hanover, NJ
Document TitleYearSource
Efficacy and tolerability of two single-day regimens of triclabendazole for fascioliasis in Peruvian children.2015Revista da Sociedade Brasileira de Medicina Tropical